The Central Drugs Standard Control Organisation granted approval for the drug's use in combination with Durvalumab for the ...

AstraZeneca Pharma India Ltd. has received approval from CDSCO to import and sell Lynparza (Olaparib) in India. Lynparza will ...

Olaparib in combination with Durvalumab is indicated for the maintenance treatment of adult patients with advanced or ...

This approval establishes the use of Olaparib in combination with Durvalumab as a maintenance treatment for adult patients ...

Lynparza, in combination with Durvalumab, was also approved as a treatment for maintenance use by adult patients whose ...

In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organisation ...

Emcure's growth will be driven by upbeat prospects that the company has across markets in India, Canada and Rest of World, ...

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from ...

Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg in the U.S. market.

New Delhi, Nov 26 (PTI) AstraZeneca Pharma India Ltd on Tuesday said it has received approval from the Indian drug regulator ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing problem of antibiotic resistance. The Fund – set up as a public-private partnership by ...